期刊文献+

病毒巨噬细胞炎症蛋白vMIP-Ⅰ和vMIP-Ⅱ在Kaposi's肉瘤患者中的表达及意义

The expression and clinical significance of viral macrophage inflammatory protein vMIP-Ⅰ and vMIP-Ⅱ in Kapsi's sarcoma patients
原文传递
导出
摘要 目的 初步探明KSHV编码的病毒巨噬细胞炎症蛋白vMIP-Ⅰ和vMIP-Ⅱ在新疆经典型Kaposi's sarcoma(KS)患者的肉瘤组织、血液、唾液和尿液中的表达情况.方法 对8例新疆经典KS患者的新鲜冰冻肉瘤组织、血液、唾液和尿液标本进行基因组DNA提取,应用PCR扩增各标本中的vMIP-Ⅰ和vMIP-Ⅱ基因.结果 8例新疆经典型KS患者的肉瘤组织、血液、唾液和尿液中均获得较好的基因组DNA;同时8例组织标本全部扩增出vMIP-Ⅰ、vMIP-Ⅱ基因,但是8例患者的血液、唾液和尿液标本都未出现vMIP-Ⅰ和vMIP-Ⅱ基因表达.结论 新疆经典型KS患者肉瘤组织中均检测到vMIP-Ⅰ和vMIP-Ⅱ基因片段的表达,为深入研究卡波氏肉瘤的血管形成机制提供初步的依据. Objective To observe the expression in sarcoma tissue,blood,salivaand urine of KSHV-encoded virus macrophage inflammatory protein vMIP-Ⅰ,vMIP-Ⅱ.Methods Genomic DNA was extracted from samples in 8 classic Kapsi' s sarcoma patients of Xinjiang,vMIP-Ⅰ and vMIP-Ⅱ gene were amplified by PCR.Results Genomic DNA were detected from sarcoma tissue,blood,saliva and urine of 8 classic Kapsi' s sarcoma patients,while vMIP-Ⅰ and vMIP-Ⅱ were amplified from all tissue samples,but the expression of vMIP-Ⅰ and vMIP-Ⅱ in blood,saliva and urine was negtive.Conclusions There is special expression of vMIP-Ⅰ and vMIP-Ⅱ in Kapsi' s sarcoma tissue.It provides a preliminary basis for further study of the mechanism of angiogenesis Kaposi's sarcoma.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2015年第5期421-424,共4页 Chinese Journal of Experimental and Clinical Virology
基金 中国科学院上海巴斯德研究所/新疆医学大学第一附属医院联合免疫实验室种子基金(GRMY-2011-02)
关键词 病毒巨噬细胞炎症蛋白 卡波氏肉瘤 卡波氏肉瘤相关疱疹病毒 肉瘤 Virus macrophage inflammatory protein Kaposi's sarcoma Kaposi's sarcoma- associated herpesvirus Sarcoma
  • 相关文献

参考文献14

  • 1Chang Y, Cesarman E, Pessin M, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated kaposi' s sarcoma. Science, 1994, 266 : 1865- 1869.
  • 2Wamburn G, Masenga EJ, Moshi EZ, et al. HIV-asseciated and non-HIV associated types of Kaposi' s sarcoma in an African population in Tanzania. Status of immune suppression and HHV- 8 seroprevalence. Eur J Dermatol, 2006, 16:677-682.
  • 3Mercader M, Taddeo B, Panella JR, et al. Induction of HH-8 lyric cycle replication by inflammatory cytokines produced by HIV-I -infected T cells. Am J Pathol,2000, 156 : 1961-1971.
  • 4Pantanowitz L, Khammissa, RA, Lemmer J, ct al. Oral HIV- associated Kaposi' s sarcoma. J Oral Pathol meal,2013,42:201- 207.
  • 5Arvanitakis L, Geras-Raaka E, Varma A, et al. Human herpesvirus KSHV encodes a constitutively active Gpreteincoupled receptor linked to cell proliferation. Nature, 1997,6614:347-350.
  • 6Shoo W, Fernandez E, sachpatzidis A, ctal, CCR2 and CCR5 receptor-binding properties of herpesvirus-8 Vmip-II based on sequence analysis and its solution structure. Eur J Biochcm, 2001, 268:2948-2959.
  • 7Nakano K, Katano H, Tadagaki K, et al. Novel monoclonal antibodies for identification of multicentric Castleman's disease;Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II. Virology, 2012, 425:95-102.
  • 8I-Iaque N$, Fallon JT, Pan JJ, et al. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle ceil chemotaxis and metalloproteinaseo2 secretion. Blood, 2004, 103 : 1296-1304.
  • 9Fatahzadeh M, Schwartz RA, Oral Kaposi's sarcoma: a review and update. Int J Dermatol, 2013, 52:666-672.
  • 10华兴,陈宏,张光,刘俊云,孙晗笑.重组病毒巨噬细胞炎性蛋白致畸胎研究及骨髓微核实验[J].中国新药与临床杂志,2005,24(1):53-56. 被引量:3

二级参考文献12

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部